10 studies found for:    lcp-tacro
Show Display Options
Rank Status Study
1 Completed LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
Condition: Autoimmune Hepatitis
Interventions: Drug: LCP-Tacro (tacrolimus);   Drug: Azathioprine
2 Completed
Has Results
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Conditions: Renal Failure;   Tremors
Interventions: Drug: Prograf;   Drug: LCP-Tacro
3 Completed
Has Results
Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients
Condition: Liver Failure
Interventions: Drug: LCP -Tacro;   Drug: Prograf
4 Completed
Has Results
Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant
Condition: Renal Failure
Interventions: Drug: LCP-Tacro tablets;   Drug: Prograf
5 Completed
Has Results
Pharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients
Condition: Liver Failure
Interventions: Drug: LCP Tacro;   Drug: Prograf
6 Completed
Has Results
Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients
Condition: Renal Failure
Interventions: Drug: LCP Tacro (tacrolimus);   Drug: Prograf
7 Completed
Has Results
Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients
Conditions: Kidney Failure;   Renal Failure
Interventions: Drug: Tacrolimus (Tacro™);   Drug: Prograf
8 Completed
Has Results
Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx
Condition: Renal Failure
Interventions: Drug: Prograf (tacrolimus);   Drug: LCP-Tacro
9 Completed
Has Results
Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily
Condition: Renal Failure
Interventions: Drug: LCP-Tacro;   Drug: Prograf
10 Completed Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily.
Condition: Renal Failure
Interventions: Drug: LCP-Tacro;   Drug: Tacrolimus

Indicates status has not been verified in more than two years